Hafsa Arshad
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hafsa Arshad has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Aqsa Qasim Zafar
Department of Bioinformatics and Biosciences Capital University of Science and Technology Islamabad Pakistan
2 shared publications - Rao Mubashar Ali
Department of Bioinformatics and Biosciences Capital University of Science and Technology Islamabad Pakistan
2 shared publications Alishba Sarwat
Capital University of Science and Technology, Islamabad, Pakistan
1 shared publication- Anushay Shahab
Capital University of Science and Technology, Islamabad, Pakistan
1 shared publication Emaan Fatima
Capital University of Science and Technology, Rawalpindi, Pakistan
1 shared publicationLaiba Mahmood
Department of Bioinformatics and Biosciences Capital University of Science and Technology Islamabad Pakistan
1 shared publication
Latest Publications
- 3 September 2026
- Published by Wiley in Biotechnology and Applied Biochemistry
A Comprehensive Review of Exopolysaccharides From Lactic Acid Bacteria: Production, Characterization, and Applications in Food and Health
Lactic acid bacteria (LAB) produce exopolysaccharides (EPSs), which are beneficial in food and health applications because of their varied structural and functional characteristics. These EPSs are attracting a lot of interest. Homopolysaccharides (HoPSs) and heteropolysaccharides (HePSs) are two types of LAB‐derived EPS that differ in their monosaccharide compositions and physicochemical properties. These biopolymers are produced through processes, such as extracellular synthesis and Wzx/Wzy‐dependent mechanisms, which are controlled by environmental and genetic variables like pH, temperature, fermentation duration, and carbon‐to‐nitrogen ratios. In dairy products, like yogurt and cheese, EPS improves texture, moisture retention, and shelf life by acting as natural thickeners, stabilizers, and emulsifiers. They are also perfect for clean‐label formulations due to their biocompatibility and biodegradability. In addition to its use in food, EPS has anticancer, antioxidant, immunomodulatory, cholesterol‐lowering, and antidiabetic benefits. They alter gut microbiota, enhance intestinal health, and interact with immunological receptors (such as toll‐like receptors [TLRs]). Furthermore, EPS exhibits promise in medicinal applications like biofilm inhibition, wound healing, and drug delivery systems. Large‐scale applications are restricted by issues including low yield and high manufacturing costs, notwithstanding their potential. To overcome these obstacles, developments in genetic engineering and fermentation optimization are essential. The biosynthesis, structural variety, and multifunctional roles of LAB‐EPS in food innovation and health promotion are highlighted in this review, which also highlights future research areas to increase their industrial and therapeutic value.
- 3 September 2026
- Published by Wiley in Biotechnology and Applied Biochemistry
A Comprehensive Review of Exopolysaccharides From Lactic Acid Bacteria: Production, Characterization, and Applications in Food and Health
Lactic acid bacteria (LAB) produce exopolysaccharides (EPSs), which are beneficial in food and health applications because of their varied structural and functional characteristics. These EPSs are attracting a lot of interest. Homopolysaccharides (HoPSs) and heteropolysaccharides (HePSs) are two types of LAB‐derived EPS that differ in their monosaccharide compositions and physicochemical properties. These biopolymers are produced through processes, such as extracellular synthesis and Wzx/Wzy‐dependent mechanisms, which are controlled by environmental and genetic variables like pH, temperature, fermentation duration, and carbon‐to‐nitrogen ratios. In dairy products, like yogurt and cheese, EPS improves texture, moisture retention, and shelf life by acting as natural thickeners, stabilizers, and emulsifiers. They are also perfect for clean‐label formulations due to their biocompatibility and biodegradability. In addition to its use in food, EPS has anticancer, antioxidant, immunomodulatory, cholesterol‐lowering, and antidiabetic benefits. They alter gut microbiota, enhance intestinal health, and interact with immunological receptors (such as toll‐like receptors [TLRs]). Furthermore, EPS exhibits promise in medicinal applications like biofilm inhibition, wound healing, and drug delivery systems. Large‐scale applications are restricted by issues including low yield and high manufacturing costs, notwithstanding their potential. To overcome these obstacles, developments in genetic engineering and fermentation optimization are essential. The biosynthesis, structural variety, and multifunctional roles of LAB‐EPS in food innovation and health promotion are highlighted in this review, which also highlights future research areas to increase their industrial and therapeutic value.
- 7 November 2025
- Published by IGI Global Scientific Publishing
- p. 171-190
Gut-Brain Axis and Microbiome Modulation by Dietary Bioactives
The gut microbiota is a key component of the complex, bidirectional communication system that connects the central nervous system with the gastrointestinal tract. This chapter examines the way in which dietary bioactive, including short-chain fatty acids, polyphenols, probiotics, and prebiotics, alter the gut microbiota and have an impact on the gut-brain axis's neurological, hormonal, immunological, and metabolic pathways. Vagal and endocrine signaling immunological modulation, and gut barrier integrity maintenance are important mechanisms. The chapter also covers the impact of dysbiosis on mental and neurological illnesses, the role of microbial metabolites in brain function, and the therapeutic potential of certain dietary strategies. The standardization, bioavailability, and personalization of these analyses continue to present difficulties despite encouraging preclinical and clinical results. Future research should concentrate on customized diet based on microbiota profiles and comprehensive clinical trials to verify efficacy and safety.
- 7 November 2025
- Published by IGI Global Scientific Publishing
- p. 171-190
Gut-Brain Axis and Microbiome Modulation by Dietary Bioactives
The gut microbiota is a key component of the complex, bidirectional communication system that connects the central nervous system with the gastrointestinal tract. This chapter examines the way in which dietary bioactive, including short-chain fatty acids, polyphenols, probiotics, and prebiotics, alter the gut microbiota and have an impact on the gut-brain axis's neurological, hormonal, immunological, and metabolic pathways. Vagal and endocrine signaling immunological modulation, and gut barrier integrity maintenance are important mechanisms. The chapter also covers the impact of dysbiosis on mental and neurological illnesses, the role of microbial metabolites in brain function, and the therapeutic potential of certain dietary strategies. The standardization, bioavailability, and personalization of these analyses continue to present difficulties despite encouraging preclinical and clinical results. Future research should concentrate on customized diet based on microbiota profiles and comprehensive clinical trials to verify efficacy and safety.